Last reviewed · How we verify
NCT07212673
Combining Digital Cognitive-behavior Therapy With Mindfulness Training for Binge Eating Disorder
NA trial testing CBT-based Mindful Courage in Binge Eating Disorder in 40 participants. Currently enrolling.
1 October 2027
Quick facts
| Lead sponsor | Yeshiva University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 2 November 2025 |
| Primary completion | 1 October 2027 |
| Estimated completion | 1 October 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CBT-based Mindful Courage
- Coached Self-Monitoring
Conditions studied
- Binge Eating Disorder — all drugs for Binge Eating Disorder →
Sponsor
Yeshiva University
Who can join
Adults 18 to 70, any sex, with Binge Eating Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will evaluate the acceptability and feasibility of a 16-session digital mindfulness-based and cognitive behavioral therapy (CBT) intervention for binge eating disorder (BED) + coached self-monitoring vs. a coached self-monitoring intervention. This study is a pilot randomized controlled trial.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Combining Digital Cognitive Behavioral Therapy With Mindfulness Training for Binge Eating Disorder: Protocol for a Feasibility Trial.
Sala M, Roos C, Ascarrunz D, Stern CM, et al · · 2026 · PMID 42061840 · DOI 10.2196/91761
Verify or expand the search:
- PubMed search for NCT07212673
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Binge Eating Disorder
Currently open trials in the same condition.
- NCT07327203 — Video-based Guided Self Help Dialectical Behavior Therapy for Binge Eating Disorder · NA · recruiting
- NCT06847399 — Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder · Phase 2 · recruiting
- NCT07042672 — Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity · recruiting
- NCT06807489 — Disordered Eating Risk in Pediatric Obesity Treatment Using a Digi-Physical Tool · active not recruiting
Other Yeshiva University trials
Trials by the same sponsor.
- NCT06604299 — Digital Mindfulness Meditation-enhanced Cognitive Behavioral Therapy (CBT-MM) for Binge Eating Disorder · NA · completed
- NCT06150612 — Unwinding Anxiety for Migraine: Pilot · NA · unknown
- NCT05753410 — App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa · NA · completed
- NCT06781840 — Promoting Health Through Play Program: Improving Parent and Child Outcomes · NA · recruiting
- NCT05031611 — Intuitive Eating for Disordered Eating · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07212673 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yeshiva University
- Last refreshed: 4 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07212673.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing